Emerald Advisers »

Nektar Therapeutics shares owned by Emerald Advisers

Quarter-by-quarter ownership of Nektar Therapeutics (NKTR) shares owned by Emerald Advisers from 13F filings

Historical chart of Emerald Advisers investment in Nektar Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Nektar Therapeutics held by Emerald Advisers consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Nektar Therapeutics by Emerald Advisers

Quarter filed Position value Share count Share price at filing
2025-09-30 $18M 323k 56.90

More positions owned by Emerald Advisers

Kratos Defense & Security Solutions (KTOS)
Credo Technology Group Holding (CRDO)
AeroVironment (AVAV)
Rambus (RMBS)
Lumentum Hldgs (LITE)
TTM Technologies (TTMI)
Bloom Energy Corp (BE)
Modine Manufacturing (MOD)
Guardant Health (GH)
Varonis Sys (VRNS)
Travere Therapeutics (TVTX)
RadNet (RDNT)
Sitime Corp (SITM)
National Vision Hldgs (EYE)
Ban (TBBK)

View all positions for Emerald Advisers

Top funds holding Nektar Therapeutics

Susquehanna International
BVF
Vanguard Group
Citadel Advisors
Farallon Capital Management
BlackRock
Millennium Management
Two Sigma Investments
Nantahala Capital Management
22NW
Emerald Advisers
Leucadia National Corporation
Dr. Jeffrey R. Jay, M.D.
PRIMECAP Management Company
UBS Group

View all funds holding Nektar Therapeutics